Hims & Hers Health, Inc.(HIMS)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
HIMS | 6.82 B | - | 38.20% | -5.51% | -$0.64 | -32.03% | 4.77x | 0.00% | $57.45 | $13.74 |
LH | 26.21 B | 26.73x | 5.80% | 6.99% | $12.09 | 11.73% | 0.79x | 0.91% | $341.07 | $242.07 |
GH | 21.82 B | - | 44.30% | -38.33% | -$3.50 | - | - | 0.00% | $191.05 | $64.00 |
BTSG | 12.35 B | 55.24x | 23.00% | 2.55% | $1.13 | 13.04% | 1.16x | 0.00% | $73.75 | $29.01 |
DVA | 11.19 B | 14.81x | 5.20% | 6.05% | $11.84 | 88.48% | 12.42x | 0.00% | $247.49 | $101.00 |
Peer Valuation & Performance Analysis
Peer group analysis for Hims & Hers Health, Inc. (HIMS) compared to its primary competitors (including LH, GH, BTSG) reveals distinct metrics. HIMS trades at a valuation discount relative to its competitors, with a P/E ratio of -45.6x versus the peer average of 12.6x (representing a 463% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, HIMS's revenue growth of 38.2% exceeds the peer average of 19.6%, highlighting its competitive strength and market share gains. Additionally, its net margin of -5.5% is comparable to the peer average of -5.7%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• HIMS ranks #0 in P/E ratio, #2 in revenue growth, and #4 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $28.00 | $30.02 | $27.75 | $29.21 | 10,516,330 | +3.77% |
| 2026-10-19 | $28.49 | $29.00 | $27.53 | $28.15 | 7,486,400 | +0.29% |
| 2026-10-16 | $29.51 | $30.00 | $27.53 | $28.07 | 11,023,500 | -4.46% |
| 2026-10-15 | $26.88 | $29.65 | $26.33 | $29.38 | 16,305,200 | +5.99% |
| 2026-10-14 | $29.26 | $29.68 | $27.57 | $27.72 | 11,071,800 | -6.70% |
| 2026-10-13 | $29.83 | $30.38 | $28.73 | $29.71 | 9,776,800 | -3.04% |
| 2026-10-12 | $30.92 | $31.79 | $30.33 | $30.64 | 8,935,800 | -0.91% |
| 2026-10-09 | $28.34 | $31.45 | $28.31 | $30.92 | 16,031,700 | +10.19% |
| 2026-10-08 | $29.20 | $29.62 | $27.49 | $28.06 | 15,056,700 | -5.01% |
| 2026-10-07 | $28.87 | $29.92 | $28.75 | $29.54 | 5,460,700 | +0.24% |
| 2026-10-06 | $30.08 | $30.08 | $29.07 | $29.47 | 8,804,600 | -0.67% |
| 2026-10-05 | $28.91 | $30.04 | $28.80 | $29.67 | 7,996,600 | +2.31% |
| 2026-10-02 | $30.08 | $30.61 | $28.55 | $29.00 | 10,080,500 | -1.02% |
| 2026-10-01 | $29.66 | $29.88 | $28.64 | $29.30 | 7,940,700 | -1.64% |
| 2026-09-30 | $29.16 | $31.03 | $29.09 | $29.79 | 14,520,500 | +3.80% |
Explore More Analysis for HIMS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.